{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:44Z","timestamp":1772165924702,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013483","name":"Betsi Cadwaladr University Health Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uveitic glaucoma commonly leads to a more intense optic nerve damage than other types of glaucoma, causing glaucomatous optic nerves and visual field defects. Anterior uveitis is the most commonly associated risk factor. Surgical intervention is usually indicated when all medical treatment has failed. We report five-year results for 16 eyes of uveitic glaucoma managed with viscocanalostomy (VC)\/Phaco viscocanalostomy (PVC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective analysis on all uveitic glaucoma cases meeting a five-year follow up was completed. All patients were managed surgically with either viscocanalostomy (VC) or phacoviscocanalostomy (PVC). Outcomes evaluated included intraocular pressures measurement pre-listing, on day 1, year 1 to year 5. Complete success rate was defined as achieving an intraocular pressure (IOP) lower than 21\u00a0mmHg or reduced by 30% without medications, and qualified success was achieved when IOP was lower than 21\u00a0mmHg or a reduction in IOP of 30% with topical medical therapy\u2009\u00b1\u2009Laser goniopuncture (LGP). If further surgeries were required to reduce IOP due to glaucoma progression then they were classified as a failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 16 patients with uveitic glaucoma were reviewed. Complete success was seen in 75% of patients at year 1, 50% of patients at year 3 and 19% of patients in year 5. Conversely qualified success was achieved in 94% of patients at year 1, 86% of patients at year 3 and 75% of patients at year 5. In the group of patients requiring further surgery, 50% of patients had previous surgeries, including cataract surgery, trabeculectomy and viscocanalostomy. There was a mean number of 4 pre-operative drops before their primary surgery and a mean drop in eye medications of 1.1 at 5\u00a0years follow-up. Success rates were prognostically linked to lower mean number of interventions and lower percentage of previous surgeries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There remains a significant paucity of information in the utilization of PVC in uveitic glaucoma. The advantage of nonpenetrating glaucoma surgery (NPGS) includes the lack of entry into the anterior chamber and the avoidance of an iridectomy which may reduce intraocular inflammation and postoperative complications. Our study shows that non-penetrating surgery is successful in treating advanced uveitic glaucoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12893-021-01176-5","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T08:04:45Z","timestamp":1618819485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the long-term efficacy and effectiveness of Viscocanalostomy and combined phacoemulsification with Viscocanalostomy in the treatment of patients with uveitic glaucoma: 5-year follow up data"],"prefix":"10.1186","volume":"21","author":[{"given":"Adonis El","family":"Salloukh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdus Samad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"issue":"5","key":"1176_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jcjo.2014.07.001","volume":"49","author":"E Kalin-Hajdu","year":"2014","unstructured":"Kalin-Hajdu E, Hammamji K, Gagn\u00e9 S, et al. Outcome of viscodilation and tensioning of Schlemm\u2019s canal for uveitic glaucoma. Can J Ophthalmol. 2014;49(5):414\u20139.","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"1176_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0161-6420(92)31950-5","volume":"99","author":"CJ Patitsas","year":"1992","unstructured":"Patitsas CJ, Rockwood EJ, Meisler DM, et al. Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease. Ophthalmology. 1992;99(4):594\u20139.","journal-title":"Ophthalmology"},{"issue":"3","key":"1176_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10384-015-0372-6","volume":"59","author":"SM Iverson","year":"2015","unstructured":"Iverson SM, Bhardwaj N, Shi W, et al. Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation. Jpn J Ophthalmol. 2015;59(3):179\u201386.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"1176_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0886-3350(99)80078-9","volume":"25","author":"R Stegmann","year":"1999","unstructured":"Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. 1999;25(3):316\u201322.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"1176_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1755-3768.2009.01759.x","volume":"88","author":"M-L Vuori","year":"2010","unstructured":"Vuori M-L. Molteno aqueous shunt as a primary surgical intervention for uveitic glaucoma: Long-term results. Acta Ophthalmol. 2010;88(1):33\u20136.","journal-title":"Acta Ophthalmol"},{"key":"1176_CR6","first-page":"1","volume":"2015","author":"FJ Mu\u00f1oz-Negrete","year":"2015","unstructured":"Mu\u00f1oz-Negrete FJ, Moreno-Monta\u00f1\u00e9s J, Hern\u00e1ndez-Mart\u00ednez P, et al. Current approach in the diagnosis and management of Uveitic glaucoma. Biomed Res Int. 2015;2015:1\u201313.","journal-title":"Biomed Res Int"},{"issue":"3","key":"1176_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jcrs.2003.10.029","volume":"30","author":"E Miserocchi","year":"2004","unstructured":"Miserocchi E, Carassa RG, Bettin P, et al. Viscocanalostomy in patients with glaucoma secondary to uveitis. J Cataract Refract Surg. 2004;30(3):566\u201370.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"1176_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/09273949509069109","volume":"3","author":"HM Towler","year":"1995","unstructured":"Towler HM, Bates AK, Broadway DC, et al. Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis. Ocul Immunol Inflamm. 1995;3(3):163\u201370.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"1176_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0002-9394(99)00185-3","volume":"128","author":"P Stavrou","year":"1999","unstructured":"Stavrou P, Murray PI. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol. 1999;128(4):434\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1176_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00061198-200206000-00005","volume":"11","author":"EM Ceballos","year":"2002","unstructured":"Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with Antiproliferative agents in Uveitic glaucoma. J Glaucoma. 2002;11(3):189\u201396.","journal-title":"J Glaucoma"},{"issue":"2","key":"1176_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/IJG.0b013e3182685167","volume":"23","author":"K Iwao","year":"2014","unstructured":"Iwao K, Inatani M, Seto T, et al. Long-term outcomes and Prognostic factors for Trabeculectomy with Mitomycin C in eyes with Uveitic glaucoma. J Glaucoma. 2014;23(2):88\u201394.","journal-title":"J Glaucoma"},{"issue":"5","key":"1176_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10792-008-9247-x","volume":"29","author":"SA Al Obeidan","year":"2008","unstructured":"Al Obeidan SA, Osman EA, Al-Muammar AM, et al. Efficacy and safety of deep sclerectomy in uveitic glaucoma. Int Ophthalmol. 2008;29(5):367\u201372.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"1176_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0181-5512(06)73782-2","volume":"29","author":"K Souissi","year":"2006","unstructured":"Souissi K, El Afrit MA, Trojet S, et al. Deep sclerectomy for the management of uveitic glaucoma. J Fr Ophtalmol. 2006;29(3):265\u20138.","journal-title":"J Fr Ophtalmol"},{"issue":"2","key":"1176_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/eye.2009.82","volume":"24","author":"B Dupas","year":"2009","unstructured":"Dupas B, Fardeau C, Cassoux N, Bodaghi B, LeHoang P. Deep sclerectomy and trabeculectomy in uveitic glaucoma. Eye. 2009;24(2):310\u20134.","journal-title":"Eye"},{"issue":"1","key":"1176_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/09273948.2013.870213","volume":"23","author":"SA Al Obeidan","year":"2014","unstructured":"Al Obeidan SA, Osman EA, Mousa A, Al-Muammar AM, Abu El-Asrar AM. Long-term evaluation of efficacy and safety of deep Sclerectomy in Uveitic glaucoma. Ocul Immunol Inflamm. 2014;23(1):82\u20139.","journal-title":"Ocul Immunol Inflamm"},{"key":"1176_CR16","unstructured":"Leen MM, Mills RP. (2003). Low postoperative intraocular pressure. In: Spaeth GL , Saunders (ed.), Ophthalmic Surgery; Principles and Practice (pp. 379\u2013387). Philadelphia, PA."},{"issue":"1","key":"1176_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ajo.2007.03.013","volume":"144","author":"TG Papadaki","year":"2007","unstructured":"Papadaki TG, Zacharopoulos IP, Pasquale LR, et al. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144(1):62\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1176_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3129\/i08-082","volume":"43","author":"R Rachmiel","year":"2008","unstructured":"Rachmiel R, Trope GE, Buys YM, et al. Ahmed glaucoma valve implantation in uvietic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol. 2008;43(4):462\u20137.","journal-title":"Can J Ophthalmol"},{"issue":"12","key":"1176_CR19","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/S0161-6420(02)01294-0","volume":"109","author":"EM Ceballos","year":"2002","unstructured":"Ceballos EM, Parrish RK, Schiffman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology. 2002;109(12):2256\u201360.","journal-title":"Ophthalmology"},{"issue":"10","key":"1176_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1755-3768.2009.01759.x","volume":"88","author":"ML Vuori","year":"2010","unstructured":"Vuori ML. Molteno aqueous shunt as a primary surgical intervention for uveitic glaucoma:long-term results. Acta Ophthalmol. 2010;88(10):33\u20136.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"1176_CR21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3928\/1542-8877-20020301-05","volume":"33","author":"G Kleinmann","year":"2002","unstructured":"Kleinmann G, Katz H, Pollack A, et al. Comparison of trabeculectomy with mitomycin C with or without phacoemulsification and lens implantation. Ophthalmic Surg Lasers. 2002;33(2):102\u20138.","journal-title":"Ophthalmic Surg Lasers"},{"issue":"7","key":"1176_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1136\/bjo.87.7.850","volume":"87","author":"J Lochhead","year":"2003","unstructured":"Lochhead J, Casson RJ, Salmon JF. Long term effect on intraocular pressure of phacotrabeculectomy compared to trabeculectomy. Br J Ophthalmol. 2003;87(7):850\u20132.","journal-title":"Br J Ophthalmol"},{"key":"1176_CR23","unstructured":"Cioffi GA, Friedmann DS, Pfeiffer N. (2005). Combined cataract\/ trabeculectomy. In: Weinreb RN, Crows JG, (ed.), Glaucoma Surgery: Open Angle Glaucoma. (pp. 65\u201371). The Hague."},{"issue":"2","key":"1176_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1442-9071.2008.01702.x","volume":"36","author":"PK Wishart","year":"2008","unstructured":"Wishart PK, Wishart MS, Choudhary A, et al. Long-term results of viscocanalostomy in pseudoexfoliative and primary open angle glaucoma. Clin Experiment Ophthalmol. 2008;36(2):148\u201355.","journal-title":"Clin Experiment Ophthalmol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-021-01176-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-021-01176-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-021-01176-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T21:18:21Z","timestamp":1619903901000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-021-01176-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1176"],"URL":"https:\/\/doi.org\/10.1186\/s12893-021-01176-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-41621\/v1","asserted-by":"object"}]},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Formal ethics approval for this project was not required as this was deemed an audit on clinical practice by the Wales Research Ethics Committee REC 5. REC reference number 16\/WA\/0345.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study was granted ethics approval from the Wales Research Ethics Committee.Institutional approval details available at the request of the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare we have received no financial support for the content of this article. The authors declare that they have no competing interests, and no financial arrangements exist which may be interpreted as having the potential to bias the outcome of this case.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}